Sputum availability and quality in country-level TB prevalence surveys

Sputum availability and quality in country-level TB prevalence surveys

Saved in:

Bibliographic Details
Main Authors:	P. Papadopoulou, M. Gaeddert, A. Gupta-Wright, C.M. Denkinger, F.M. Marx
Format:	Article
Language:	English
Published:	International Union Against Tuberculosis and Lung Disease (The Union) 2024-11-01
Series:	IJTLD Open
Subjects:	tuberculosis people living with hiv xpert mtb/rif national-level tb surveys
Online Access:	https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000011/art00010
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Sequential testing with Xpert MTB/RIF assay for diagnosis of tuberculous meningitis in Maharaj Nakorn Chiang Mai University Hospital
by: Poramed Winichakoon, et al.
Published: (2025-01-01)

Stool Xpert® MTB/RIF Ultra for TB diagnosis in children: experience from a national scale-up programme
by: S. Kabir, et al.
Published: (2024-10-01)

PneumoniaCheck, a novel aerosol collection device, permits capture of airborne Mycobacterium tuberculosis and characterisation of the cough aeromicrobiome in people with tuberculosis
by: Tinaye L. Chiyaka, et al.
Published: (2024-08-01)

TB drug susceptibility testing in high fluoroquinolone resistance settings
by: F. Saluzzo, et al.
Published: (2024-05-01)

Assessment of Rifampicin Resistance in Presumptive Tuberculosis Cases at Dadeldhura Hospital of Sudurpaschim Province of Nepal
by: Madan Singh Bohara
Published: (2025-02-01)

Innovations in TB Screening and Preventive Therapy Services for PLHIV in Yogyakarta City, Indonesia
by: Dani Catrianiningsih, et al.
Published: (2025-01-01)

3HP preventive treatment among children and adolescents with HIV and child household contacts of TB patients
by: A. Kinikar, et al.
Published: (2024-09-01)

Applicability of TB-LAMP test for diagnosis of pulmonary TB among HIV-positive individuals
by: B. Muriithi, et al.
Published: (2025-01-01)

Modeling TB and HIV co-infections
by: Lih-Ing W. Roeger, et al.
Published: (2009-08-01)

Cartridge-based sequencing for bedaquiline resistance detection from sputum
by: J.D. Limberis, et al.
Published: (2024-09-01)

Children and providers’ perspectives on once-weekly rifapentine and isoniazid TB preventive therapy
by: A.J. Marthinus, et al.
Published: (2025-01-01)

Analytical and clinical validation of a novel MeltPlus TB-NTM/RIF platform for simultaneous detection of Mycobacterium tuberculosis complex, Non-Tuberculous Mycobacteria and rifampicin resistance
by: Zhuo Wang, et al.
Published: (2025-02-01)

Tuberculosis vaccines and therapeutic drug: challenges and future directions
by: Yajing An, et al.
Published: (2025-01-01)

TB prevention activities in the WHO European Region
by: A. Matteelli, et al.
Published: (2024-08-01)

Mapping TB incidence across districts in Uganda to inform health program activities
by: N.J. Henry, et al.
Published: (2024-05-01)

A survey of the effectiveness of centralized consilia in providing advice on drug-resistant TB
by: A. Vasquez, et al.
Published: (2024-07-01)

Prevalence of TB-related symptoms and self-reported disability among adult TB survivors
by: A.K. McDonald, et al.
Published: (2024-12-01)

Time to be seen and heard: Including children’s and adolescents’ voices in the South African TB response
by: C Goslett, et al.
Published: (2024-07-01)

Updated treatment guidelines for drug-resistant TB: how safe are clofazimine-based regimens?
by: E. Pontali, et al.
Published: (2024-11-01)

Modelling the human immune response mechanisms to mycobacterium tuberculosis infection in the lungs
by: Gesham Magombedze, et al.
Published: (2006-07-01)

More is needed to end TB: commentary on the United Nations High-Level Meeting on TB
by: G. B. Migliori, et al.
Published: (2024-01-01)

Impact of heteroresistance on treatment outcomes of people with drug-resistant TB
by: R. Crowder, et al.
Published: (2024-10-01)

Role of Chest Radiography in Diagnosing Pulmonary Tuberculosis, Does Every Suspected Case Needs GeneXpert MTB; A Cross-Sectional Study
by: Mujahid Raza, et al.
Published: (2025-02-01)

Mathematical analysis of the transmission dynamics of HIV/TB coinfection in the presence of treatment
by: Oluwaseun Sharomi, et al.
Published: (2007-12-01)

Factors that shape the integration of HIV and TB services in Zomba District, Malawi
by: Alex F. Maseko, et al.
Published: (2025-02-01)

Identification of core biomarkers for tuberculosis progression through bioinformatics analysis and in vitro research
by: Zhanpeng Chen, et al.
Published: (2025-01-01)

TB and poverty: the effect of rifampicin-resistant TB on household income
by: A. Ciobanu, et al.
Published: (2024-04-01)

The TB burden in East Java, Indonesia, post-COVID-19
by: S. Palupi, et al.
Published: (2024-08-01)

Global reporting on TB in children and adolescents: how far have we come and what remains to be done?
by: S. Verkuijl, et al.
Published: (2024-01-01)

Commitment, partnerships and operational research: three priorities for 11 EMR countries to achieve TB elimination
by: M. van den Boom, et al.
Published: (2024-01-01)

Burden and challenges in managing TB infection among people with occupational exposure to silica in India
by: B. Kalottee, et al.
Published: (2024-11-01)

Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European Region
by: G.B. Migliori, et al.
Published: (2024-03-01)

Clinical spectrum of disease and outcomes in children with Omicron SARS-COV-2 infection in Cape Town, South Africa
by: C. Bekker, et al.
Published: (2024-01-01)

Gambaran Tingkat Kepatuhan Pengobatan Pasien TB Paru
by: Endang Martini, et al.
Published: (2024-10-01)

Characteristics of and treatment outcomes in rifampicin-intolerant patients
by: R. Mangat, et al.
Published: (2024-04-01)

HIV and diabetes impair M. tuberculosis-specific interferon-gamma responses on QuantiFERON-TB Gold Plus testing
by: J.S. Zifodya, et al.
Published: (2024-05-01)

The intersection of TB and health financing: defining needs and opportunities
by: W.A. Wells, et al.
Published: (2024-09-01)

Determinant of catastrophic costs associated with treatment for rifampicin-resistant TB in households in the Republic of Moldova
by: A. Ciobanu, et al.
Published: (2024-06-01)

Rethinking latent TB? Think again
by: R.E. Chaisson, et al.
Published: (2024-08-01)

Immune-neuroendocrine reactivity and features of tuberculosis in pregnancy
by: Anna Starshinova, et al.
Published: (2025-02-01)